Aruna Bio Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Private

  • Employees
  • 40

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $346K

  • Investors
  • 8

Aruna Bio General Information

Description

Developer of a neural exosome platform designed to prepare medicine for the treatment of neural diseases. The company's platform harnesses the natural abilities of neural exosomes to cross the blood-brain barrier and enhance the body's anti-inflammatory, self-repair, and protective mechanisms to treat a range of neurodegenerative disorders, enabling drug manufacturers to prepare the drug for stroke, traumatic brain, and spinal cord injuries.

Contact Information

Website
www.arunabio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Drug Discovery
Primary Office
  • 184 Collins Industrial Boulevard
  • Suite A
  • Athens, GA 30601
  • United States
+1 (678) 000-0000

Aruna Bio Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aruna Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
16. Grant 01-Jun-2022 $346K 000.00 Completed Pre-Clinical Trials
15. Later Stage VC 14-Apr-2021 000.00 000.00 Completed Pre-Clinical Trials
14. Debt - PPP 09-Apr-2020 00000 000.00 Completed Pre-Clinical Trials
13. Grant 18-Sep-2019 00.00 000.00 Completed Pre-Clinical Trials
12. Later Stage VC 24-Jul-2019 000.00 000.00 Completed Pre-Clinical Trials
11. Later Stage VC 19-Jul-2018 00.000 00.00 Completed Pre-Clinical Trials
10. Grant 01-Sep-2017 00.00 00.00 Completed
9. Later Stage VC 28-Apr-2017 00.000 00.00 Completed Pre-Clinical Trials
8. Grant 01-Jan-2017 $725K $164K Completed Pre-Clinical Trials
7. Grant 01-Jan-2014 $300K $164K Completed Pre-Clinical Trials
To view Aruna Bio’s complete valuation and funding history, request access »

Aruna Bio Patents

  • 6

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 2

    Pending

  • 000

    Expiring in next 12 mo

Aruna Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4142737-A1 Binding agents and uses thereof for central nervous system delivery Pending 27-Apr-2020 00000000000
AU-2021264512-A1 Binding agents and uses thereof for central nervous system delivery Pending 27-Apr-2020 0000000000
CA-3176495-A1 Binding agents and uses thereof for central nervous system delivery Pending 27-Apr-2020 0000000000
US-20230173094-A1 Binding agents and uses thereof for central nervous system delivery Pending 27-Apr-2020 0000000000
EP-4054631-A1 Extracellular vesicles and uses thereof for antibody delivery Pending 04-Nov-2019 A61K47/6901
To view Aruna Bio’s complete patent history, request access »

Aruna Bio Executive Team (7)

Name Title Board Seat Contact Info
Stephen From Chief Executive Officer & Board Member
Tracey Stice Co-Founder, Chief Operating Officer & Executive Vice President, Manufacturing and Process Development
Steven Stice Ph.D Co-Founder, Chief Scientific Officer & Board Member
Amy Doherty Corporate Controller
You’re viewing 4 of 7 executive team members. Get the full list »

Aruna Bio Board Members (15)

Name Representing Role Since
Barry Storey Self Board Member 000 0000
Darren DeVore Self Board Member 000 0000
Harold Ingalls Aruna Bio Board Member 000 0000
John Mangan Jr. Self Board Member 000 0000
John Richard Ph.D Georgia Venture Partners Board Member 000 0000
You’re viewing 5 of 15 board members. Get the full list »

Aruna Bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aruna Bio Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Irrus Investments Angel Group Minority 000 0000 000000 0
National Institutes of Health Government Minority 000 0000 000000 0
Eshelman Ventures Venture Capital Minority 000 0000 000000 0
Evolution VC Partners Venture Capital Minority 000 0000 000000 0
GRA Venture Fund Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial